A review of the changes to the licensing of influenza vaccines in Europe

Summary of knowledge gaps related to quality and efficacy of current influenza vaccines

(2014) Michael Pfleiderer et al.   VACCINE

Complex Correlates of Protection After Vaccination

(2013) S. A. Plotkin   CLINICAL INFECTIOUS DISEASES

Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine

(2013) S. Rockman et al.   JOURNAL OF VIROLOGY

Reproducibility of assays for influenza vaccine immunogenicity determination: progress towards consistency

(2012) Ralf Wagner et al.   Expert Review of Vaccines

Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines

(2012) Glendie Marcelin et al.   REVIEWS IN MEDICAL VIROLOGY

Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines—An effective EU regulatory approach

(2012) Ralf Wagner et al.   VACCINE

Influenza Hemagglutination-Inhibition Antibody Titer as a Correlate of Vaccine-Induced Protection

(2011) Suzanne E. Ohmit et al.   JOURNAL OF INFECTIOUS DISEASES

Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis

(2011) Michael T Osterholm et al.   LANCET INFECTIOUS DISEASES

Hemagglutination Inhibition Antibody Titers as a Correlate of Protection for Inactivated Influenza Vaccines in Children

(2011) Steven Black et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Registration of influenza vaccines for children in Europe

(2011) Marta Granström et al.   VACCINE

Reproducibility of serology assays for pandemic influenza H1N1: Collaborative study to evaluate a candidate WHO International Standard

(2011) John M. Wood et al.   VACCINE

New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors

(2009) Jennifer Clark Nelson et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Evaluation of serological trials submitted for annual re-licensure of influenza vaccines to regulatory authorities between 1992 and 2002

(2009) A.C.G. Voordouw et al.   VACCINE

Safety of trivalent inactivated influenza vaccines in adults: Background for pandemic influenza vaccine safety monitoring

(2009) Claudia Vellozzi et al.   VACCINE